Clinical value

For the patient

Infection and missed cancers are key challanges in prostate biopsy. The Forsvall Biopsy System reduces bacterial transfer by 96%* and helps the urologist hit the target**, with no change in clinical workflow.

Order now

Key features

Addressing Complications

The Forsvall needle reduces bacterial transfer by 96%*, aiming to lower complication rates, enhancing procedural safety and clinical outcome for your patients.

Reduced Time & Cost

Improved accuracy enables fewer cores, shorter procedures and lower pathology costs. Fewer complications reduce infection related expenses.

Designed by Urologists – for Urologists

Designed to be faster, safer and easier to use. Without change in workflow. No training is needed regardless of transperineal or transrectal prostate biopsy.

* PMID: 3399975

** Forsvall 100% target collection compared to 4% for Tru-Cut in an 8 mm difficult to hit target ; in vitro results presented at the EAU in Madrid 2025